WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disorder: drug trial targets autoimmune attack
Disease control OngoingThis study tests an experimental drug called HMPL-523 for people with warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system mistakenly destroys red blood cells, causing fatigue and other symptoms. The trial involves 110 adults aged 18 to 75 and ai…
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New hope for anemia in CLL patients: acalabrutinib trial shows promise
Disease control OngoingThis study tests a drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) who also have a type of anemia where the immune system attacks red blood cells. The goal is to see if the drug can control the anemia after other treatments have failed. Only 4 people …
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC